August 10, 2021 – Tumor testing for advanced bladder cancer to predict treatment efficacy
The Erasmus Mc Bladder Cancer Centre and VitroScan BV join forces on the EVITA project: “Tumor testing for advanced bladder cancer to predict treatment efficacy” The project was awarded with an Erasmus MC-TKI-LSH Match Call (PPP) allowance.
Project coordinators Dr. Joost Boormans, and Dr. Tahlita Zuiverloon: “Together with our affiliated hospitals we have succeeded to establish regional care paths for patients with MIBC and we believe this has substantially improved the quality of care for our patients. However, we are still in desperate need of reliable predictive tests, which could aid in clinical decision making. We are very pleased with the opportunity to leverage our expertise with that of VitroScan within this important study project.”
July 28, 2021 – Towards the development of a catheter decision tool
The functional urology research group was awarded a ZonMw grant to perform a study that will lead to the development of a catheter decision tool. Five percent of the total expenditure on outpatient medical devices in the Netherlands is spent on catheters for clean intermittent catheterization. This puts intermittent catheters in the top four of highest expenditures on outpatient medical devices in the Netherlands. The current study, starting in December 2021, will identify catheter user satisfaction in the Dutch population and determine medical professionals’ view and behavior regarding prescribing clean intermittent catheterization as a last step before the development and validation of a catheter decision tool.